First AD

Second AD

Breast Cancer

ELI-22-OSD1261 - /clinical/colorectal-cancer

 Breast Cancer condition center page is a comprehensive resource for clinical news and expert insights on various types of breast cancer, including those that are triple negative, hormone receptor positive, and/or HER2 positive. This page features news articles, interviews in written and video format, and podcasts that focus on treatment advances and ongoing research in breast cancer.

Insights

Insights is an expert interview video series of leading oncologists that provides in-depth reports and feature segments profiling leaders in a range of oncology disciplines, including breast cancer, lung cancer, gastrointestinal cancers, genitourinary cancers, gynecologic cancers, and hematologic malignancies. Most episodes feature 2 clinicians discussing the latest oncology advances in clinical practice. 

Improving Outcomes in Metastatic HER2+ Breast Cancer: Translating Evidence to Clinical Practice  

Mays Cancer Center at UT Health San Antonio

Cancer Centers

Partner

A key opinion leader in breast cancer management shares insight on the treatment armamentarium for patients with HER2+ disease. 

Overview of the HER2+ Metastatic Breast Cancer Treatment Armamentarium

Landscape of HER2+ Metastatic Breast Cancer: Patient Overview

HER2+ Metastatic Breast Cancer: An Evolving Treatment Armamentarium

HER2+ Metastatic Breast Cancer: Factors in Selecting 2L Therapy and Beyond

Role of T-DXd in Patients With HER2+ Metastatic Breast Cancer and CNS Metastasis

HER2+ Breast Cancer With CNS or Leptomeningeal Metastases: Future Directions in Care

Patient Profile: A 68-Year-Old Woman With HER2+ Metastatic Breast Cancer 

Factors in Selecting Third-Line Therapy for HER2+ Metastatic Breast Cancer 

Role of Brain Metastases and Quality of Life in Treatment Decisionmaking 

Addressing Resistance to HER2-Targeted Therapy in Metastatic Breast Cancer 

HER2+ Metastatic Breast Cancer: Unmet Needs and Future Directions in Care